Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Naccarelli

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Cardiology. Heart & Vasculature|July 21, 2020
Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II studySarah Berlin, Andreas Goette, Luciana Summo, et al.
American Heart Journal|March 30, 2013
Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryBenjamin A Steinberg, DaJuanicia N Holmes, Michael D Ezekowitz, et al.
Journal of Cardiovascular Electrophysiology|April 14, 2010
The impact of new and emerging clinical data on treatment strategies for atrial fibrillationEric N Prystowsky, John Camm, Gregory Y H Lip, et al.
Journal of the American College of Cardiology|December 17, 2016
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II RegistryBenjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
Journal of the American Heart Association|September 16, 2015
Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)Benjamin A Steinberg, Sunghee Kim, Laine Thomas, et al.
JACC. Clinical Electrophysiology|May 17, 2018
Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF RegistryAmit Noheria, Peter Shrader, Jonathan P Piccini, et al.
American Heart Journal|April 29, 2014
Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Sunghee Kim, Gregg C Fonarow, et al.
Clinical Cardiology|May 26, 2017
Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantationEric Black-Maier, Sunghee Kim, Benjamin A Steinberg, et al.
Heart (British Cardiac Society)|June 28, 2020
Patterns of oral anticoagulation use with cardioversion in clinical practiceKyle Geurink, DaJuanicia Holmes, Michael D Ezekowitz, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 31, 2021
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II)Larry R Jackson, Peter Schrader, Laine Thomas, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Cardiology. Heart & Vasculature|July 21, 2020
Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II studySarah Berlin, Andreas Goette, Luciana Summo, et al.
American Heart Journal|March 30, 2013
Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryBenjamin A Steinberg, DaJuanicia N Holmes, Michael D Ezekowitz, et al.
Journal of Cardiovascular Electrophysiology|April 14, 2010
The impact of new and emerging clinical data on treatment strategies for atrial fibrillationEric N Prystowsky, John Camm, Gregory Y H Lip, et al.
Journal of the American College of Cardiology|December 17, 2016
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II RegistryBenjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
Journal of the American Heart Association|September 16, 2015
Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)Benjamin A Steinberg, Sunghee Kim, Laine Thomas, et al.
JACC. Clinical Electrophysiology|May 17, 2018
Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF RegistryAmit Noheria, Peter Shrader, Jonathan P Piccini, et al.
American Heart Journal|April 29, 2014
Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Sunghee Kim, Gregg C Fonarow, et al.
Clinical Cardiology|May 26, 2017
Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantationEric Black-Maier, Sunghee Kim, Benjamin A Steinberg, et al.
Heart (British Cardiac Society)|June 28, 2020
Patterns of oral anticoagulation use with cardioversion in clinical practiceKyle Geurink, DaJuanicia Holmes, Michael D Ezekowitz, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 31, 2021
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II)Larry R Jackson, Peter Schrader, Laine Thomas, et al.
Pageof 3